Grogan Implies HHS Adding Part D Drugs To Int’l Pricing Index Demo

By John Wilkerson / October 9, 2019 at 5:12 PM
Investors expect HHS to include a subset of Medicare Part D drugs in the International Pricing Index demonstration after hearing White House Domestic Policy Council head Joe Grogan speak Tuesday (Oct. 8) at an event in Washington sponsored by the investment bank UBS. Medicare Part D spending dwarfs Part B spending, so adding retail drugs to the international reference pricing scheme would hurt drug industry profits even more. The Trump administration last year announced plans to base prices of Medicare...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.